Prospects for recombinant vaccines against Babesia bovis and related parasites
- PMID: 16842268
- DOI: 10.1111/j.1365-3024.2006.00849.x
Prospects for recombinant vaccines against Babesia bovis and related parasites
Abstract
Babesial parasites infect cattle in tropical and temperate regions of the world and cause significant morbidity and mortality. Discovery of protective antigens that could be used in a killed vaccine has been slow and to date there are few promising vaccine candidates for cattle Babesia. This review describes mechanisms of protective innate and adaptive immune responses to babesial parasites and different strategies to identify potentially protective protein antigens of B. bovis, B. bigemina, and B. divergens. Successful parasites often cause persistent infection, and this paper also discusses how B. bovis evades and regulates the immune response to promote survival of parasite and host. Development of successful non-living recombinant vaccines will depend on increased understanding of protective immune mechanisms and availability of parasite genomes.
Similar articles
-
Immune control of Babesia bovis infection.Vet Parasitol. 2006 May 31;138(1-2):75-87. doi: 10.1016/j.vetpar.2006.01.041. Epub 2006 Feb 28. Vet Parasitol. 2006. PMID: 16510249 Review.
-
Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.Parasite Immunol. 2005 Dec;27(12):439-45. doi: 10.1111/j.1365-3024.2005.00795.x. Parasite Immunol. 2005. PMID: 16255742
-
Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.Ann N Y Acad Sci. 2006 Oct;1081:382-96. doi: 10.1196/annals.1373.057. Ann N Y Acad Sci. 2006. PMID: 17135542
-
Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.Vet Parasitol. 2010 May 28;170(1-2):30-6. doi: 10.1016/j.vetpar.2010.02.008. Epub 2010 Feb 18. Vet Parasitol. 2010. PMID: 20207488
-
Designing blood-stage vaccines against Babesia bovis and B. bigemina.Parasitol Today. 1999 Jul;15(7):275-81. doi: 10.1016/s0169-4758(99)01471-4. Parasitol Today. 1999. PMID: 10377530 Review.
Cited by
-
Developing Anti-Babesia bovis Blood Stage Vaccines: A New Perspective Regarding Synthetic Vaccines.Int J Mol Sci. 2023 Mar 9;24(6):5219. doi: 10.3390/ijms24065219. Int J Mol Sci. 2023. PMID: 36982294 Free PMC article. Review.
-
Identification of novel immune correlates of protection against acute bovine babesiosis by superinfecting cattle with in vitro culture attenuated and virulent Babesia bovis strains.Front Immunol. 2022 Nov 18;13:1045608. doi: 10.3389/fimmu.2022.1045608. eCollection 2022. Front Immunol. 2022. PMID: 36466866 Free PMC article.
-
Immunization of Cattle With Recombinant Structural Ectodomains I and II of Babesia bovis Apical Membrane Antigen 1 [BbAMA-1(I/II)] Induces Strong Th1 Immune Response.Front Vet Sci. 2022 Jun 23;9:917389. doi: 10.3389/fvets.2022.917389. eCollection 2022. Front Vet Sci. 2022. PMID: 35812841 Free PMC article.
-
Identification and Characterization of P0 Protein as a Vaccine Candidate Against Babesia divergens, Blood Parasite of Veterinary and Zoonotic Importance.Front Vet Sci. 2022 Jan 7;8:795906. doi: 10.3389/fvets.2021.795906. eCollection 2021. Front Vet Sci. 2022. PMID: 35071386 Free PMC article.
-
Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis.Vaccines (Basel). 2022 Jan 14;10(1):123. doi: 10.3390/vaccines10010123. Vaccines (Basel). 2022. PMID: 35062784 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
